xtandi
astellas pharma europe b.v. - enzalutamidas - prostatos navikai - endokrininė terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
meropenem venus pharma
venus pharma gmbh - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 500 mg - meropenem
meropenem venus pharma
venus pharma gmbh - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 1000 mg - meropenem
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
ivabradine ingen pharma
sia ingen pharma - ivabradinas - plėvele dengtos tabletės - 7,5 mg - ivabradine
pantoprazole ingen pharma
sia ingen pharma - pantoprazolas - skrandyje neirios tabletės - 20 mg; 40 mg - pantoprazole
olopatadine unimed pharma
unimed pharma spol. s r.o. - olopatadinas - akių lašai (tirpalas) - 1 mg/ml - olopatadine
bendamustine hydrochloride boston biopharma
boston biopharma lt, uab - bendamustino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 2,5 mg/ml - bendamustine
trimetazidine ingen pharma
sia ingen pharma - trimetazidino hidrochloridas - pailginto atpalaidavimo tabletės - 35 mg - trimetazidine
levofloxacin unimed pharma
unimed pharma spol. s r.o. - levofloksacinas - akių lašai (tirpalas) - 5 mg/ml - levofloxacin